Risk for cancer and cardiovascular disease linked to air pollution, and three cancer drugs could face generic competition by 2028.

by Kevin McLaughlin

Lung cancer screening linked to lower mortality in real-world data, and researchers study unusual cancer patterns after COVID-19 infection.

by Eric Fitzsimmons

Research supports reducing the intensity of cancer treatment, and barriers can prevent members of the LGBTQ+ community from receiving cancer screening and care.

by Thomas Celona

Young adults often ignore telltale signs of colorectal cancer, and more evidence supports active surveillance for low-risk prostate cancer.

by Marci A. Landsmann

New immunotherapy approved for small cell lung cancer, and researchers investigate using urine tests to detect cancer.

by Kevin McLaughlin

Disparities in cancer outcomes shrink but persist, and FDA approval increases access to HPV screening.

by Eric Fitzsimmons

People may be able to wait longer between colonoscopies, and a trial evaluates a less invasive option for treating prostate cancer.

by Thomas Celona

Updated recommendation lowers age for breast cancer screening, and laboratory tests will undergo greater FDA oversight.

by Marci A. Landsmann

Supplemental breast screenings are not covered by Medicare, and researchers develop a treatment option for a form of eye cancer.

by Kevin McLaughlin

A urine test may help grade prostate cancers without biopsies, and states look for savings and better health in palliative care.

by Eric Fitzsimmons